Furthermore, high ALDH1 immunoexpression, regardless of the assessed tumor area, was associated with an unfavorable outcome, suggesting this marker could be used as an indicator of worst prognosis for patients with HNSCC (24,27). Here, ALDH1A1 is linked to neoplasm.